Choreo LLC’s Arrowhead Research ARWR Stock Holding History

Choreo LLC’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$513K	Buy	6,289 +72	+1%	+$5.32K	0.01%	978
2026 Q1	$390K	Sell	6,217 -471	-7%	-$29.8K	﹤0.01%	1084
2025 Q4	$450K	Buy	+6,688	New	+$328K	0.01%	968

Other funds holding ARWR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Choreo LLC's ARWR Position: Q2 2026 in Review

Choreo LLC increased its Arrowhead Research (ARWR) stake by 1.2% in Q2 2026, buying an estimated $5.32K and bringing the position to 6,289 shares worth $513K. The position accounts for 0.01% of the portfolio, ranked #978.

Choreo LLC first reported a position in ARWR in Q4 2025 and has held it in 3 quarters since. 500 funds tracked by Wall St. Rank hold ARWR as of Q2 2026.

Choreo LLC held 6,289 shares of Arrowhead Research worth $513K as of Q2 2026.
Choreo LLC bought 72 Arrowhead Research shares in Q2 2026, an estimated $5.32K.
Arrowhead Research made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #978 holding.
Choreo LLC first reported a position in Arrowhead Research in Q4 2025 and has held it in 3 quarters since.
500 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.